ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

Diabetic nephropathy (DN) is one of the main causes of renal fibrosis and is associated with high morbidity and mortality. Traditional Chinese Medicine (TCM) therapy has a long history of usage in a clinical setting and its usage is increasing. ErHuang Formula (EHF), a Chinese herbal compound, has b...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Yu-Li Shen, Yi-ping Jiang, Xiao-Qin Li, Su-Juan Wang, Ming-Hua Ma, Chun-Yan Zhang, Jian-Yong Zhu, Khalid Rahman, Li-Jun Zhang, Xin Luan, Hong Zhang
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2020-01-01
סדרה:Frontiers in Pharmacology
נושאים:
ErHuang formula
renal fibrosis
diabetic nephropathy
mechanism
JAK/STAT3
גישה מקוונת:https://www.frontiersin.org/article/10.3389/fphar.2019.01596/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים